Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 3, 2015
Exercise preferences, levels and quality of life in lung cancer survivorsH J Leach, J A Devonish, D G Bebb, et al.
Current Oncology (Toronto, Ont.)|November 23, 2018
Current landscape of immunotherapy in the treatment of solid tumours, with future opportunities and challengesN A Nixon, N Blais, S Ernst, et al.
British Journal of Cancer|September 2, 1999
Absence of mutations in the ATM gene in forty-seven cases of sporadic breast cancerD G Bebb, Z Yu, J Chen, et al.
American Journal of Surgery|December 1, 1993
Impact of adjunctive testing on the diagnosis and clinical course of patients with acute appendicitisM R Sarfati, G C Hunter, D B Witzke, et al.
Current Oncology (Toronto, Ont.)|December 23, 2017
Reasons for lack of referral to medical oncology for systemic therapy in stage IV non-small-cell lung cancer: comparison of 2003-2006 with 2010-2011J J Ko, R Tudor, H Li, et al.
Bioconjugate Chemistry|February 14, 1998
Biodistribution of 111In- and 90Y-labeled DOTA and maleimidocysteineamido-DOTA conjugated to chimeric anticarcinoembryonic antigen antibody in xenograft-bearing nude mice: comparison of stable and chemically labile linker systemsL E Williams, M R Lewis, G G Bebb, et al.
American Journal of Clinical Oncology|December 17, 2019
Real-World Adherence to Guideline-Recommended Treatment for Small Cell Lung CancerAnifat A Elegbede, Amanda J Gibson, Hao Fu, et al.
Mutation Research|May 5, 2001
Radiation induced apoptosis in ataxia telangiectasia homozygote, heterozygote and normal cellsD G Bebb, P J Warrington, G de Jong, et al.
The Journal of Pathology|August 13, 2004
Evaluation of immunohistochemical markers in non-small cell lung cancer by unsupervised hierarchical clustering analysis: a tissue microarray study of 284 cases and 18 markersN H C Au, M Cheang, D G Huntsman, et al.
Oncogene|May 18, 2010
The viral tropism of two distinct oncolytic viruses, reovirus and myxoma virus, is modulated by cellular tumor suppressor gene statusM Kim, C T Williamson, J Prudhomme, et al.
Pageof 3